ResultsFinancial Express
Gland Pharma Q2 profit rises 58%
GreyOak summary
Gland Pharma reported a 58% year-on-year increase in net profit to Rs 291 crore for Q2 FY27, driven by strong CDMO revenue. EBITDA also grew 53% to Rs 480 crore. The company launched four new molecules in the US and filed 11 ANDAs, with the stock price rising 1% on the news.
What it affects
- Gland PharmaGLANDPositive +20
Profit rose 58% to Rs 291 crore.Rolling sentiment Positive +64
Source
Read the original at Financial ExpressMore Gland Pharma news
- Five Stocks To Buy Today, November 11: Gland Pharma, Sansera Engineering, Union Bank, And MoreNDTV Profit · Stock view ·
- Gland Pharma shares rally 8% to hit 4-year-high post strong Q2Moneycontrol · Results ·
- Gland Pharma shares jump 7% to 52-week highCNBC-TV18 · Stock view ·
- Pharma shares shine: Sai, Gland, Divi's, Laurus, Glenmark surge up to 9%Business Standard · Stock view ·
- Divis, Gland, Sai Life Sciences shares hit 52-week highsBusiness Today · Stock view ·